SE8101010L - ANDROSTANKARBOTIOATER - Google Patents

ANDROSTANKARBOTIOATER

Info

Publication number
SE8101010L
SE8101010L SE8101010A SE8101010A SE8101010L SE 8101010 L SE8101010 L SE 8101010L SE 8101010 A SE8101010 A SE 8101010A SE 8101010 A SE8101010 A SE 8101010A SE 8101010 L SE8101010 L SE 8101010L
Authority
SE
Sweden
Prior art keywords
group
alpha
compounds
hydrogen
formula
Prior art date
Application number
SE8101010A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE452468B (en
Inventor
G H Phillipps
B Mcd Bain
C Williamson
I P Steeples
S B Laing
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8101010L publication Critical patent/SE8101010L/en
Publication of SE452468B publication Critical patent/SE452468B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the formula <IMAGE> in which R<1> is a fluoro-, chloro- or bromomethyl group or a 2'-fluoroethyl group, R<2> is a group COR<6> in which R<6> is a C1-3-alkyl group, or OR<2> and R<3> together form a 16 alpha ,17 alpha -isopropylidenedioxy group; R<3> is a hydrogen atom, a methyl group (which can be present in either the alpha or the ss configuration) or a methylene group; R<4> is a hydrogen, chlorine or fluorine atom; R<5> is a hydrogen or fluorine atom, and the symbol ..... is a single or double bond. The compounds have good anti-inflammatory activity, in particular on topical application. The compounds of the formula I are prepared by esterification, halogenation, reduction, elimination of protective groups and reaction at a 9,11 double bond to form a 9 alpha -halo-11ss-hydroxy group.
SE8101010A 1980-02-15 1981-02-13 ANDROSTAN CARBATIOTS, PROCEDURE FOR PREPARING THESE AND COMPOSITIONS SE452468B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8005174 1980-02-15
GB8013339 1980-04-23

Publications (2)

Publication Number Publication Date
SE8101010L true SE8101010L (en) 1981-08-16
SE452468B SE452468B (en) 1987-11-30

Family

ID=26274505

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8101010A SE452468B (en) 1980-02-15 1981-02-13 ANDROSTAN CARBATIOTS, PROCEDURE FOR PREPARING THESE AND COMPOSITIONS

Country Status (23)

Country Link
KR (1) KR850000969B1 (en)
AT (1) AT395427B (en)
AU (1) AU544517B2 (en)
BG (1) BG60700B2 (en)
CH (2) CH644615A5 (en)
CZ (1) CZ281275B6 (en)
DE (2) DE3105307A1 (en)
DK (1) DK147022C (en)
ES (5) ES499394A0 (en)
FI (1) FI70904C (en)
FR (2) FR2477156A1 (en)
HK (1) HK58385A (en)
IE (1) IE51394B1 (en)
IT (1) IT1170717B (en)
KE (1) KE3526A (en)
MX (1) MX9202717A (en)
MY (1) MY8500757A (en)
NL (2) NL191792C (en)
NZ (1) NZ196260A (en)
PT (1) PT72502B (en)
SE (1) SE452468B (en)
SG (1) SG36885G (en)
SK (1) SK403491A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817929B (en) * 1980-12-22 1982-10-27 Upjohn Co 5alpha-and 5beta-androstane-17beta-carboxylates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436549A (en) * 1972-06-15 1976-05-19 Glaxo Lab Ltd 17beta-mercaptocarbonyl-3alpha-hydroxy-steroids and their esters
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
GB1580517A (en) * 1978-04-06 1980-12-03 Fowler I Crutches

Also Published As

Publication number Publication date
SG36885G (en) 1985-11-15
NZ196260A (en) 1983-11-30
MY8500757A (en) 1985-12-31
ATA67481A (en) 1992-05-15
NL191792B (en) 1996-04-01
SK278140B6 (en) 1996-02-07
CZ281275B6 (en) 1996-08-14
DK147022B (en) 1984-03-19
NL191792C (en) 1996-08-02
ES524985A0 (en) 1985-01-01
KE3526A (en) 1985-06-07
DE3105307C2 (en) 1988-09-29
CH644615A5 (en) 1984-08-15
DE3153379C2 (en) 1992-11-19
CZ403491A3 (en) 1994-03-16
PT72502A (en) 1981-03-01
KR830005262A (en) 1983-08-03
MX9202717A (en) 1992-06-30
IE810282L (en) 1981-08-15
FR2485542A1 (en) 1981-12-31
ES8305379A1 (en) 1983-04-01
DK62381A (en) 1981-08-16
IT8147792A0 (en) 1981-02-13
FI70904B (en) 1986-07-18
FI70904C (en) 1986-10-27
ES518161A0 (en) 1984-01-16
SK403491A3 (en) 1996-02-07
ES8207194A1 (en) 1982-09-01
ES8600936A1 (en) 1985-10-16
ES532055A0 (en) 1985-10-16
PT72502B (en) 1982-02-05
AU6729881A (en) 1981-08-20
IE51394B1 (en) 1986-12-24
ES509539A0 (en) 1983-04-01
NL960029I1 (en) 1997-02-03
ES8502447A1 (en) 1985-01-01
CH651307A5 (en) 1985-09-13
AU544517B2 (en) 1985-06-06
ES499394A0 (en) 1982-09-01
NL8100707A (en) 1981-09-16
FR2477156A1 (en) 1981-09-04
KR850000969B1 (en) 1985-07-02
SE452468B (en) 1987-11-30
DK147022C (en) 1984-08-27
BG60700B2 (en) 1995-12-29
ES8402317A1 (en) 1984-01-16
DE3105307A1 (en) 1981-12-10
IT1170717B (en) 1987-06-03
FR2477156B1 (en) 1984-11-16
HK58385A (en) 1985-08-16
FR2485542B1 (en) 1983-06-10
NL960029I2 (en) 1997-04-01
AT395427B (en) 1992-12-28
FI810444L (en) 1981-08-16

Similar Documents

Publication Publication Date Title
GB1467226A (en) Radiation-sensitive prepolymers and their use for the pro duction of relief structures
FR2434803A1 (en) IMIDES AND BIS-IMIDES SUBSTITUTED WITH NITROGEN, FOR USE AS INTERMEDIATE BODIES
DK159757C (en) APPLICATION OF NAPHTHALENDER DERIVATIVES FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OR PROPHYLACY OF INFLAMMATION BY TOPIC ADMINISTRATION AND PHARMACEUTICAL PREPARATION FOR TOPICAL USE CONTAINING NAPHTHREEN
ES8306767A1 (en) Androstene 17 alpha -carbonate 17 beta -carboxylates (and carbothioates)
SE8100134L (en) THERPENOIDS, PROCEDURES FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
KR830006304A (en) Method of Preparation of Dioxide Compound
FI842815A (en) FOERENING OCH KOMPOSITION FOER THERAPEUTIC ELLER DIAGNOSTIC ANVAENDNING OCH THERAPEUTIC BEHANDLINGSMETOD.
GB1398993A (en) Triazolyl-styryl compounds
SE8101010L (en) ANDROSTANKARBOTIOATER
FR2429201A1 (en) SULFOXIDES FOR USE AS PHOTOPOLYMERIZATION INITIATING AGENTS
SE7708299L (en) PHENOXY ASSOCIATIONS AND COMPOSITIONS
FR2433553A1 (en) RESINS OF UNSATURATED POLYESTERS, NOT INHIBITED BY AIR OXYGEN, THEIR PREPARATION AND THEIR USES
FR2434161A1 (en) NEW HEXAHYDROBENZOPYRAN AND ITS PREPARATION
FR2362118A1 (en) NEW METAPHENYLENEDIAMINES AND TINCTORIAL COMPOSITIONS CONTAINING THEM
FR2386529A1 (en) 7-AMINOALKYL-3,7-DIARYL-3,3A, 4,5,6,7-HEXAHYDRO-2H-INDAZOLES AND THEIR USE AS ANTI-INFLAMMATORY
JPS54125620A (en) Preparation of diazomethane derivative
ES8307803A1 (en) Polycyclic compounds substituted on the A-ring, pharmaceutical compositions containing them, and methods of treating psoriasis with them
ES8105250A1 (en) Substituted decalins, their preparation and use.
SE7904080L (en) TERMINAL-BIFUNCTIONAL XYLITE DERIVATIVES
FR2442872A1 (en) NEW DISAZOIC COMPOUND FOR USE AS A PIGMENT AND ITS PREPARATION
ATE15184T1 (en) FLUORPHENOXYBENZYLESTER, THEIR PRODUCTION AND USE AS PESTICIDES.
ES453829A1 (en) Procedure for preparation of quinazolinones (Machine-translation by Google Translate, not legally binding)
SU683200A1 (en) α-pyridylhydrazides diaryl or dialkylglycolic acid, showing anti-inflammatory activity
SU900581A1 (en) IODIDES 2,2-DIBENZIMIDAZOLOV, possessing anti-corrosive activity
JPS5430108A (en) Diyne-type polyprenyl alcohol and hypotensive agent containing the same

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 8101010

SPCG Supplementary protection certificate granted

Free format text: 8101010, EXPIRES: 20060213

NAL Patent in force

Ref document number: 8101010-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8101010-0

Format of ref document f/p: F